Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
06/2003
06/12/2003CA2467435A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1317454A2 Caspase inhibitors and uses thereof
06/11/2003EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors
06/11/2003EP1024810A4 Method for optimizing retinal and optic nerve health
06/11/2003EP1021413B1 The preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
06/05/2003WO2003045957A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003WO2003045955A1 Use of selective potassium channel openers
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003US20030105130 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105081 Heterocyclic compounds as ligands of the GABAA receptor
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/04/2003EP1315733A2 Method for producing anellated tetrahydro-[1h]-triazoles
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003EP0775135B1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics
06/04/2003EP0759437B1 Processes for the production of 2-isocephem derivatives
06/04/2003EP0656037B1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/04/2003CN1422270A Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422155A Urease inhibitors
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110496C Tetrahydro Gamma-carbolines compound
06/03/2003US6573252 Therapy and prevention of bony disorders; improved gastrointestinal tolerability
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003043577A2 Modulators of rho c activity
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/27/2003US6569856 Treatment of feeding disorders, obesity, bulimia nervosa, sexual/reproductive disorders, depression, epileptic seizure, cardiovascular disorders, sleep disturbances
05/22/2003WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals
05/22/2003WO2003042188A1 Triazole derivative and medicinal composition containing the same
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042175A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096813 Compositions useful as inhibitors of GSK-3
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096715 Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same
05/22/2003US20030096381 Production of polyketides
05/22/2003CA2467081A1 Pyrazole derivatives as psychopharmaceuticals
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1108822C Pharmaceutical composition containing lornoxicam and disodic salt of EDTA
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation
05/20/2003CA2123606C New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
05/15/2003WO2003039258A1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
05/15/2003WO2002030357A3 Compounds and methods for modulating ccr4 function
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030091931 Benzbisazole compound and optical recording medium containing the compound
05/15/2003US20030091505 Antiserotonine agents; central nervous system disorders
05/14/2003EP1309576A1 Di(het)arylaminothiazole derivatives and their use in organic light-emitting diodes (oled's) and organic photovoltaic components
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/13/2003US6562969 Ricin inhibitors and methods for use thereof
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity
05/08/2003WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
05/08/2003WO2003037327A1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
05/08/2003WO2003037086A1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones
05/08/2003US20030087916 Pyrimidin-4-one compounds
05/08/2003US20030087888 Anticancer agents
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1307463A1 Pyrrolo 2,1-b]-[1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0931074B1 Condensed 4,5,6,7-tetrahydrobenzo c]thiophenes as enhancer for cell differentiation induction factor action
05/07/2003EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/07/2003CN1416414A Process for preparation of (R)-2-bromo-3-phenyl-propionic acid
05/06/2003US6559145 Heterocycle carboxamides as antiviral agents
05/06/2003US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction
05/06/2003CA2036905C Condensed thiazole compounds, their production and use
05/02/2003EP1305318A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo 2,1-b] 1,3]benzotiazepines
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1196167A4 Method of reducing neuronal injury or apoptosis
05/02/2003EP1121351A4 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
05/02/2003EP0662078B1 Reagents for peptide couplings
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035077A1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
05/01/2003WO2002046158A9 Piperidine/piperazine-type inhibitors of p38 kinase
05/01/2003WO2002012442A3 Heterocyclic compounds as ligands of the gabaa receptor
05/01/2003US20030083349 Antimalaria agents
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030083311 Thiazolo [4,5-b] pyridines as fungicides
05/01/2003US20030080323 Novel methine compound, material for organic luminescence element, and organic luminescence element using the same
04/2003
04/30/2003CN1413990A Epimino substituted benzene derivative
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/24/2003WO2003033497A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 152